English
Home > Products > Carfilzomib API

China Carfilzomib API Factory

Our company promises all users of the first-class products and the most satisfying post-sale service. We warmly welcome our regular and new customers to join us for Carfilzomib API,CAS NO 868540-17-4,868540-17-4,Carfilzomib, we could solve our customer problems asap and do the profit for our customer. For those who need excellent company and top quality , pls choose us , thanks !
Carfilzomib API, If you are for any reason unsure which product to select, do not hesitate to contact us and we'll be delighted to advise and assist you. This way we will be providing you with all the knowledge needed to make the best choice. Our company strictly follows "Survive by good quality, Develop by keeping good credit. " operation policy. Welcome all the clients old and new to visit our company and talk about the business. We're looking for more and more customers to create the glorious future.

Related Products

Hot Products

  • Edoxaban (TsOH salt)

    Edoxaban (TsOH salt)

    Product Name:Edoxaban (TsOH salt)
    Molecular Formula:C31H38ClN7O7S2
    Molecular Weight;720.26
    CAS Registry Number;480449-71-6
  • Tulathromycin B

    Tulathromycin B

    Product Name:Tulathromycin B
    Molecular Formula:C41H79N3O12
    Molecular Weight;806.09
    CAS Registry Number;280755-12-6
  • Fursultiamine

    Fursultiamine

    Product Name:Fursultiamine
    Molecular Formula:C17H26N4O3S2
    Molecular Weight;398.54
    CAS Registry Number;804-30-8
  • N,9-Diacetylguanine

    N,9-Diacetylguanine

    Product Name:N,9-Diacetylguanine
    Molecular Formula:C9H9N5O3
    Molecular Weight:235.2
    CAS Registry Number:3056-33-5
  • Homoharringtonine

    Homoharringtonine

    Product Name:Homoharringtonine
    Molecular Formula:C29H39NO9
    Molecular Weight;545.63
    CAS Registry Number;26833-87-4
  • Ethyl (R)-(-)-4-cyano-3-hydroxybutyate

    Ethyl (R)-(-)-4-cyano-3-hydroxybutyate

    Product Name:Ethyl (R)-(-)-4-cyano-3-hydroxybutyate
    Molecular Formula:C7H11NO3
    Molecular Weight:157.17
    CAS Registry Number:141942-85-0
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept